Marc E. Andre

Yvoir, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Journal: Haematologica
Published: May 04, 2026

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Journal: HemaSphere
Published: April 14, 2026

Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.

Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.

Journal: British journal of haematology
Published: February 25, 2026

Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party.

Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party.

Journal: The Lancet. Haematology
Published: February 03, 2026

Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study.

Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study.

Journal: Haematologica
Published: November 06, 2025

Breast Implant-Associated Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma.

Breast Implant-Associated Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma.

Journal: Case reports in hematology
Published: November 03, 2025

Chimeric antigen receptor T-cell therapy in aggressive lymphomas.

Chimeric antigen receptor T-cell therapy in aggressive lymphomas.

Journal: Current opinion in oncology
Published: July 14, 2025

An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma.

An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma.

Journal: NEJM evidence
Published: June 19, 2025

A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.

A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.

Journal: Cancer research communications
Published: May 14, 2025

Prognostic value of a simple distance index derived from PET maximum intensity projection.

Prognostic value of a simple distance index derived from PET maximum intensity projection.

Journal: Frontiers in medicine
Published: January 23, 2025

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Journal: Blood advances
Published: January 02, 2025

Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.

Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 12, 2024
Showing 1-12 of 105

Last Updated: 09/26/2026